The expression levels of ID3 and CD52 gradually increase as the degree of ESCC differentiation declines, suggesting that the degree and progression of ESCC differentiation may be assessed by the expression levels of ID3 or CD52 (Fig. 4C). The gene discussed is CD52; the disease is esophageal squamous cell carcinoma.